| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.1830200325 |
| P698 | PubMed publication ID | 2318253 |
| P50 | author | Luigina Romani | Q37386517 |
| P2093 | author name string | Appella E | |
| Fioretti MC | |||
| Ullrich SJ | |||
| Puccetti P | |||
| Grohmann U | |||
| Mage MG | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens | Q28339796 | ||
| Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation | Q33564130 | ||
| Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug | Q35978848 | ||
| Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine | Q36348769 | ||
| Monoclonal antibodies to mouse major histocompatibility complex antigens. | Q36649460 | ||
| Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line | Q37598857 | ||
| Immunogenetics of cell surface antigens of mouse leukemia | Q37706562 | ||
| Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirus-induced tumors | Q39497014 | ||
| Chemical xenogenization of experimental tumors | Q39658154 | ||
| T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis | Q41324725 | ||
| Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound | Q41610482 | ||
| Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant | Q41912401 | ||
| Humoral response against murine lymphoma cells xenogenized by drug treatment in vivo | Q42662407 | ||
| Xenogenization of tumor cells by transfection with plasmid containing env gene of Friend leukemia virus | Q43829622 | ||
| Dimeric character of fibronectin, a major cell surface-associated glycoprotein | Q44394890 | ||
| New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells | Q44428016 | ||
| Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations | Q48487777 | ||
| Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response | Q53565621 | ||
| Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens. | Q54175019 | ||
| Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. | Q54359895 | ||
| High resolution two-dimensional electrophoresis of basic as well as acidic proteins | Q58492650 | ||
| Cell-mediated immunity to chemically xenogenized tumors—III. Generation of monoclonal antibodies interfering with reactivity to novel antigens | Q58855450 | ||
| Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant | Q58855453 | ||
| Dna methylating activity in murine lymphoma cells xenogenized by triazene derivatives | Q58855455 | ||
| Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain | Q58855460 | ||
| Antigenic Changes of L5178Y Lymphoma After Treatment With 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide In Vivo 2 | Q67440168 | ||
| Immunization of mice and rabbits by intrasplenic deposition of nanogram quantities of protein attached to Sepharose beads or nitrocellulose paper strips | Q68994653 | ||
| Cellular immune response to a drug-treated L5178Y lymphoma subline | Q70025782 | ||
| Preparative nonlytic separation of Lyt2+ and Lyt2- T lymphocytes, functional analyses of the separated cells and demonstration of synergy in graft-vs.-host reaction of Lyt2+ and Lyt2- cells | Q72089938 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 629-636 | |
| P577 | publication date | 1990-03-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70 | |
| P478 | volume | 20 |
| Q48059214 | A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. |
| Q58855438 | Antigen-specific cytolysis of infected cells in murine candidiasis |
| Q62662280 | Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL) |
| Q58855442 | Candida albicans-specific Ly-2+ lymphocytes with cytolytic activity |
| Q41528286 | Immunogenic properties of retroviral protein p15e from drug‐treated murine mastocytoma P815 |
| Q58855440 | O 6-Methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents |
| Q38730989 | Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors |
| Q72524400 | Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity |
Search more.